92 related articles for article (PubMed ID: 11550502)
21. [Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
Pozdniakova VP; Nestetrova LIa; Smirnova LB; Iakovlev VP; Blatun LA; Koshil' OI; Fedorov SM; Bakalova LA; Strachunskiĭ LS; Kurmanova KB
Antibiot Khimioter; 1997; 42(7):20-3. PubMed ID: 9334143
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG
Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436
[TBL] [Abstract][Full Text] [Related]
23. [A case of joint toxicity from pefloxacin in the treatment of nephrotic syndrome in a child].
Diouf B; Djoneidi M; Niang A; Diallo S; Moreira-Diop T; Bao O
Dakar Med; 1996; 41(2):105-7. PubMed ID: 9827103
[TBL] [Abstract][Full Text] [Related]
24. [Bacteremia and Pasteurella multocida pneumonia revealing HIV infection].
Bernier C; Bouvard E; Saidi F; Parrot A; Meyniel D
Rev Pneumol Clin; 1999 Dec; 55(6):403-6. PubMed ID: 10685476
[TBL] [Abstract][Full Text] [Related]
25. Pefloxacin versus cefuroxime axetil for single-dose therapy of acute uncomplicated lower urinary tract infections in women.
Krcmery S; Hromec J; Gulla D
J Chemother; 1995 Nov; 7 Suppl 4():168-9. PubMed ID: 8904145
[No Abstract] [Full Text] [Related]
26. Fluoroquinolones in children: poorly defined risk of joint damage.
Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
[TBL] [Abstract][Full Text] [Related]
27. [Study of pefloxacin concentration in blood and sputum in the aged pneumonia patients with impairment of renal function].
Ma L; Sun C; Wu J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):596-8. PubMed ID: 11770420
[TBL] [Abstract][Full Text] [Related]
28. [Fluoroquinolones in clinical practice. Pefloxacin (abaktal, peflacine)].
Fomina IP; Iudin SM; Kashina LB
Antibiot Khimioter; 1995; 40(11-12):70-7. PubMed ID: 8830644
[No Abstract] [Full Text] [Related]
29. [Abactal (pefloxacin) in the treatment of gonorrheal and mixed infections].
Kisina VI
Antibiot Khimioter; 1993 Dec; 38(12):42-3. PubMed ID: 8085909
[No Abstract] [Full Text] [Related]
30. [Use of pefloxacin in the treatment of patients with purulent wounds of soft tissues].
Blatun LA; Puchkova LS; Navashin PS; Iakovlev VP; Svetykhin AM
Antibiot Khimioter; 1999; 44(1):20-2. PubMed ID: 10095920
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of pefloxacin in the treatment of complicated relapsing erysipelas].
Kurmanova KB; Sulełmenova ZI; Sensatkhit K; Uteulin MN
Antibiot Khimioter; 1997; 42(12):25-8. PubMed ID: 9480650
[TBL] [Abstract][Full Text] [Related]
32. [Application of new strategies in the treatment of patients with purulent sepsis complications].
Medvets'kyĭ IeB; Sukhariev II; Kryzhevs'kyĭ VV; Nychytaĭlo MIu; Vlaĭkov HH; Steblyna VIe; Hyndych LO; Furmanenko OD
Klin Khir; 2001 Jul; (7):62-4. PubMed ID: 11688292
[No Abstract] [Full Text] [Related]
33. Quinolones-induced acral erythema.
Bonnetblanc JM; Bernard P
Therapie; 1996; 51(5):601-2. PubMed ID: 9138405
[No Abstract] [Full Text] [Related]
34. Seven Achilles tendinitis including 3 complicated by rupture during fluoroquinolone therapy.
Ribard P; Audisio F; Kahn MF; De Bandt M; Jorgensen C; Hayem G; Meyer O; Palazzo E
J Rheumatol; 1992 Sep; 19(9):1479-81. PubMed ID: 1433021
[TBL] [Abstract][Full Text] [Related]
35. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin.
Asli B; Bienvenu B; Cordoliani F; Brouet JC; Uzunhan Y; Arnulf B; Malphettes M; Rybojad M; Fermand JP
Arch Dermatol; 2007 Aug; 143(8):1046-50. PubMed ID: 17709664
[TBL] [Abstract][Full Text] [Related]
36. Release of pefloxacin bonded on catheters after intraperitoneal implantation in mice.
Carsenti-Etesse H; Forget B; Bensoussan M; Bensoussan F; Dellamonica P
Drugs; 1995; 49 Suppl 2():304-6. PubMed ID: 8549342
[No Abstract] [Full Text] [Related]
37. Effects of norfloxacin or pefloxacin on the oral and intestinal microflora of bone marrow transplant patients.
Giuliano M; Gentile G; Pantosti A; Micozzi A; Arcese W; Martino P
J Chemother; 1989 Jul; 1(4 Suppl):726-7. PubMed ID: 16312609
[No Abstract] [Full Text] [Related]
38. Effect of subinhibitory concentrations of pefloxacin in infection in mice due to susceptible or resistant strains.
Carsenti-Etesse H; Bensoussan M; Bensoussan F; Durant J; Pradier C; Mondain V; Bernard E; Dellamonica P
Drugs; 1995; 49 Suppl 2():276-8. PubMed ID: 8549331
[No Abstract] [Full Text] [Related]
39. [Pefloxacin in the treatment of the bone and joint infections].
Maiello A; Dassio G; Calvo MM; Gramoni A
Minerva Med; 1999; 90(1-2):33-7. PubMed ID: 10388461
[TBL] [Abstract][Full Text] [Related]
40. Comparative effect of gentamicin and pefloxacin treatment on the late stages of mouse typhoid.
Bonina L; Costa GB; Mastroeni P
New Microbiol; 1998 Jan; 21(1):9-14. PubMed ID: 9497924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]